Table 3.
Convergent validity (i.e. Spearman’s correlation coefficients) between PedsQL GCS total score (parent-reported) and CHU9D utility score (child-reported) for children aged 10–17 years old by clinical condition status and age group
| Conditions | B cohort 10–11 years old |
B cohort 12–13 years old |
B cohort 14–15 years old |
K cohort 14–15 years old |
K cohort 16–17 years old |
Total (B and K cohorts) 10–17 years old |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Spearman’s correlation coefficient | N | Spearman’s correlation coefficient | N | Spearman’s correlation coefficient | N | Spearman’s correlation coefficient | N | Spearman’s correlation coefficient | N | |
| Overall sample without any of the 6 conditions | 2736 | 0.17 | 2419 | 0.19 | 2288 | 0.19 | 2464 | 0.24 | 2168 | 0.26 | 12,075 |
| Asthma | 452 | 0.24 | 403 | 0.20 | 372 | 0.21 | 409 | 0.24 | 321 | 0.30 | 1957 |
| Anxiety/depression | 161 | 0.22 | 217 | 0.23 | 225 | 0.24 | 305 | 0.30 | 319 | 0.13 | 1227 |
| ADHD | 119 | 0.17 (NS) | 114 | 0.21 | 114 | 0.15 (NS) | 95 | 0.13 (NS) | 77 | − 0.18 (NS) | 519 |
| Autism/Asperger’s | 117 | 0.25 | 123 | 0.17 (NS) | 126 | 0.21 | 77 | 0.09 (NS) | 81 | 0.08 (NS) | 524 |
| Epilepsy | 19 | − 0.34 (NS) | 16 | − 0.06 (NS) | 16 | 0.05 (NS) | 14 | 0.27 (NS) | 8 | 0.39 (NS) | 73 |
| Diabetes (type 1) | 11 | 0.59 (NS) | 14 | 0.42 (NS) | 16 | 0.46 (NS) | 14 | 0.62 | 9 | − 0.33 (NS) | 64 |
ADHD attention deficit hyperactivity disorder, B baby, CHU9D Child Health Utility 9D, K kindergarten, NS non-significant, PedsQL GCS Pediatric Quality of Life Inventory™ v4.0 Generic Core Scales
Values are Spearman’s correlation coefficients with those ≥ 0.4 threshold in bold
NS correlation p value > 0.05